HCA Healthcare hospital in Richmond, VA temporarily halts NICU admissions after unexplainable fractures found in three babies. Investigation underway.

Discover how women in healthcare leadership roles drove significant improvements in their organizations through mindset shifts, transparency, and prioritizing ...

Here are six takeaways from the letter: Cleveland Clinic Florida's hospital-at-home program has treated more than 2,800 patients, for conditions including heart failure, pneumonia and kidney ...

Barclay Berdan became CEO of Arlington-based Texas Health Resources in 2014 and over the last decade has built a strong culture with an eye toward growth.

Doug Boysen, president and CEO of Corvallis, Ore.-based Samaritan Health Services, plans to step down from the role in 2025. Mr. Boysen is working with the board to create a CEO transition plan, ...

Philip Hall, a 48-year-old pharmacist of Jamestown, Tenn., has been arrested and charged with six counts of aggravated identity theft and nine counts of healthcare fraud. Mr. Hall owned and operated ...

Here are four hospital and health system CFO moves that Becker's has reported on since Dec. 23: 1. Rob Wood was promoted to CFO of Somers Point, N.J.-based Shore Medical Center. 2. Orlando Health St.

Shore Medical Center in Somers Point, N.J., appointed two new executives Dec. 26. Rob Wood was promoted to CFO after spending 37 years with the system. He previously served as director of finance and ...

Epic Systems and Oracle Health are anticipating big years in 2025. Oracle plans to launch a new AI-powered EHR to optimize clinical workflows and further personalize the patient experience. The ...

BradenHealth acquires Perry Community Hospital in Tennessee, plans to rebuild and restore services. Learn more about the acquisition and BradenHealth's plans f ...

Tristan Hall, senior vice president and CHRO of Columbus-based OhioHealth, began his journey with the system as a high school student — an experience that has significantly shaped his approach to ...

Zealand Pharma's GLP-2 drug candidate fails to gain FDA approval due to request for additional trial to confirm efficacy and safety.